Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan advised Tellus Therapeutics on the deal.Tellus Therapeutics, Inc., a biopharmaceutical company developing TT-20 as a treatment for white matter…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
